Updated 2026-09 · 4 min read
Semax is a synthetic heptapeptide derived from a fragment of ACTH (the 4-10 sequence), studied in neuroprotective and cognitive research literature. This guide reviews the reported mechanism for in-vitro research context.
Mechanism
In preclinical models, Semax has been studied for effects on BDNF and other neurotrophic signaling, and for neuroprotective endpoints. Much of the literature originates from Russian research groups where the peptide has been a long-standing subject of study.
In the catalog
This material is synthesized from publicly available preclinical literature and industry documentation for qualified laboratory researchers. It is not medical, veterinary, therapeutic, or diagnostic advice. All compounds are supplied and discussed solely for in-vitro laboratory research and are not for human or animal use.